NCLEX Review Guide: Hyperbilirubinemia in Newborns

Definition and Process

• Hyperbilirubinemia is a condition characterized by elevated serum bilirubin levels in the blood, which may manifest as jaundice (yellowing of the skin and sclera). In newborns, this occurs due to the breakdown of fetal hemoglobin combined with the immature liver's inability to efficiently conjugate and excrete bilirubin.
• Bilirubin is produced from the breakdown of red blood cells, specifically the heme portion. Unconjugated (indirect) bilirubin is fat-soluble, cannot be excreted, and can cross the blood-brain barrier. Conjugated (direct) bilirubin is water-soluble and can be excreted in bile and urine.

Types of Hyperbilirubinemia

• Physiologic Jaundice: Normal process appearing after 24 hours of life, peaking at 3-5 days, and resolving by 7-10 days. Bilirubin levels typically remain below 12-15 mg/dL.
• Pathologic Jaundice: Appears within 24 hours of birth, rises rapidly (>5 mg/dL/day), peaks above 15 mg/dL, and persists beyond 7 days in term infants or 14 days in preterm infants.
• Breast Milk Jaundice: Occurs after 3-5 days of life due to substances in breast milk that inhibit bilirubin conjugation, potentially lasting 3-12 weeks.
• Breastfeeding Jaundice: Results from insufficient intake of breast milk leading to dehydration and decreased bilirubin excretion.

Risk Factors

• Maternal factors: ABO or Rh incompatibility, maternal diabetes, certain medications, and ethnicity (Asian, Native American).
• Neonatal factors: Prematurity, male gender, bruising/cephalohematoma, delayed cord clamping, polycythemia, and genetic disorders (G6PD deficiency, Crigler-Najjar syndrome).
• Feeding factors: Poor feeding, delayed bowel movements, and dehydration.

Clinical Presentation

• Jaundice progresses in a cephalocaudal direction (head to toe): face and sclera first, then trunk, and finally extremities. This progression correlates roughly with increasing bilirubin levels.
• Blanching the skin with digital pressure reveals underlying yellow discoloration, which is most visible in natural daylight.
• In dark-skinned infants, examine the sclera, gums, palms, and soles for jaundice.

Diagnostic Testing

• Transcutaneous Bilirubin (TcB): Non-invasive screening tool that measures bilirubin levels through the skin. Values correlate well with serum levels but may be less accurate in darker-skinned infants or those undergoing phototherapy.
• Total Serum Bilirubin (TSB): Gold standard for diagnosis, measuring both conjugated and unconjugated bilirubin. Results are plotted on hour-specific nomograms to determine risk and need for treatment.
• Additional tests may include direct (conjugated) bilirubin, complete blood count, blood type and Coombs test, reticulocyte count, and liver function tests to determine the underlying cause.

Complications

• Acute Bilirubin Encephalopathy (ABE): Reversible neurological dysfunction due to high levels of unconjugated bilirubin crossing the blood-brain barrier. Early signs include lethargy, poor feeding, and hypotonia, progressing to irritability, high-pitched cry, and hypertonia.
• Kernicterus: Permanent neurological damage from bilirubin toxicity, characterized by athetoid cerebral palsy, hearing loss, visual and dental abnormalities, and intellectual impairment.

Phototherapy

• Phototherapy uses specific wavelengths of light (blue-green spectrum, 430-490 nm) to convert unconjugated bilirubin to water-soluble isomers that can be excreted without liver conjugation.
• Effectiveness depends on light intensity (irradiance), surface area exposed, and distance between infant and light source. Double phototherapy or triple phototherapy may be used for higher bilirubin levels.

Phototherapy Nursing Interventions

1. Expose maximum skin surface area (dress infant only in diaper).
2. Cover eyes with proper eye shields to prevent retinal damage; remove during feeding.
3. Reposition infant every 2 hours to maximize skin exposure.
4. Monitor vital signs and temperature every 2-4 hours (increased risk of hyperthermia).
5. Increase feeding frequency to promote hydration and bilirubin excretion.
6. Maintain accurate intake and output; weigh diapers if necessary.
7. Monitor for skin integrity, rashes, and bronze baby syndrome.
8. Provide parent education and support.

Exchange Transfusion

• Reserved for severe hyperbilirubinemia unresponsive to phototherapy or with signs of bilirubin encephalopathy. This procedure removes the infant's bilirubin-laden blood and replaces it with donor blood.
• Typically performed in a NICU setting, with small aliquots (5-10 mL) of blood removed and replaced simultaneously through umbilical vessels.

Intravenous Immunoglobulin (IVIG)

• Used in cases of isoimmune hemolytic disease (Rh or ABO incompatibility) with rapidly rising bilirubin levels despite intensive phototherapy.
• IVIG blocks antibody-mediated hemolysis, reducing the rate of bilirubin production and potentially avoiding exchange transfusion.

Supportive Management

• Feeding support: Encourage frequent breastfeeding (8-12 times/day) or formula feeding (every 2-3 hours) to promote gastrointestinal motility and bilirubin excretion.
• Hydration: Monitor for dehydration (dry mucous membranes, decreased urine output, weight loss >10% of birth weight) and supplement feeds if needed.
• Parent education: Explain the condition, treatment rationale, and follow-up plan. Reassure parents about the temporary nature of physiologic jaundice.

Preventive Strategies

• Early and frequent feeding (within 1-2 hours of birth and at least 8-12 times/day) to promote meconium passage and reduce enterohepatic circulation of bilirubin.
• Avoid dehydration by ensuring adequate intake and monitoring output (at least 4-6 wet diapers/day by day 4).
• Early identification of at-risk infants using risk assessment tools and pre-discharge bilirubin screening.

Discharge Education

Parent Teaching Points

1. Explain jaundice, its causes, and potential complications.
2. Demonstrate how to assess for jaundice (pressing on skin, checking sclera).
3. Review feeding techniques and frequency (8-12 times/day).
4. Teach signs of adequate hydration (6-8 wet diapers/day, 3-4 stools/day).
5. Explain warning signs requiring immediate attention: increased jaundice, lethargy, poor feeding, high-pitched cry, arched back.
6. Provide written information about follow-up appointments.

Follow-up Care

• Schedule follow-up appointments based on age at discharge and risk assessment. High-risk infants may need follow-up within 24 hours of discharge.
• Serial bilirubin measurements may be needed until jaundice resolves or bilirubin levels are clearly declining.
• Long-term follow-up for infants who had severe hyperbilirubinemia to monitor for developmental concerns, hearing impairment, or neurological sequelae.

Physiologic vs. Pathologic Jaundice

Breastfeeding Jaundice vs. Breast Milk Jaundice

Direct vs. Indirect Hyperbilirubinemia

NCLEX Question Strategies

• For questions about jaundice timing, remember that appearance within 24 hours is always pathologic and requires immediate evaluation.
• When prioritizing assessments, focus on neurological signs that might indicate bilirubin encephalopathy (lethargy, poor feeding, high-pitched cry).
• For management questions, consider the infant's age, bilirubin level, and risk factors when determining appropriate interventions.

Common Pitfalls

• Pitfall #1: Assuming all jaundice is physiologic. Remember to consider timing, progression, and associated symptoms.
• Pitfall #2: Focusing only on bilirubin levels without considering age-specific risk factors and nomograms.
• Pitfall #3: Recommending discontinuation of breastfeeding as a first-line intervention.
• Pitfall #4: Neglecting the importance of follow-up after discharge, especially for infants discharged before 72 hours of age.

Quick Knowledge Checks

Self-Assessment Checklist